Company Stats

• Capital raised: Over $22 Million, including angel investors and grants ($9 Million).
• Employees: 6 (35 during technology development)
• Founded: 2012

Episode Highlights

✅ Innovation in grant acquisition by developing groundbreaking technology.
✅ Microbiome's critical role in human health and disease prevention.
✅ Revolutionary approach to microbiome mining with large-scale technology.

Episode Summary

In this episode of "Failing to Success," we welcome Ross Youngs, founder of Biosortia, to discuss the innovative process of raising grants and the transformative technology in microbiome mining. Ross reveals how Biosortia has secured around $9 million in grants and over $22 million in total capital. He explains the critical role of the microbiome in human health, noting that we have more microbial cells than human cells. Biosortia's groundbreaking technology enables large-scale extraction and analysis of untapped microbes, paving the way for significant advancements in therapeutics, agriculture, and more. This technology could revolutionize our understanding and application of microbiome science.

Chapters

00:00 Introduction to Ross Youngs and Biosortia

00:16 The Financial Journey: Grants and Capital Raised

00:56 Exploring the Microbiome: Untapped Microbes and Technology

03:34 The Revolutionary Approach to Microbiome Mining

04:59 The Impact of Microbiome on Human Health and Beyond

05:57 Scaling Up: The Future of Microbiome Mining

08:16 Closing Remarks and How to Learn More